AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2019
Mar 6, 2019
30583_dirs_2019-03-06_5ff8b1b6-2a7e-4ed1-ad35-b38c197baa21.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2019-03-04
Reporting Person: FUCHS HENRY J (President, Worldwide R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-04 | Common Stock | S | 2196 | $95.00 | Disposed | 142504 | Direct |
Footnotes
F1: Trade made pursuant to a 10b5-1 plan executed on October 30, 2018.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19